Introduction: Focusing on impacts to health-related indicators in older Japanese patients, this study analyzed both the direct influence of dialysis-related stigma and influences of its intersectionality with other stigmatized characteristics.
Methods: Data were collected through a cross-sectional survey of 7461 outpatients in dialysis facilities. Other stigmatized characteristics include lower income, lower education, disabled activities of daily living, and diabetic end-stage renal disease (ESRD) as a cause for starting dialysis treatment.
Results: The average rate of an "agree" response on dialysis-related stigma items was 18.2%. Dialysis-related stigma significantly influenced all three health-related indicators, including suspected depression, informal networks, and compliance with dietary therapy. In addition, each interaction between dialysis-related stigma and educational attainment, gender, and diabetic ESRD significantly influence one health-related indicator.
Conclusion: These results suggest that dialysis-related stigma has both a significant direct and synergic influence with other stigmatized characteristics on health-related indicators.
{"title":"Influence of dialysis-related stigma on health-related indicators in Japanese patients undergoing hemodialysis.","authors":"Hidehiro Sugisawa, Yumiko Shimizu, Tamaki Kumagai, Kanji Shishido, Yutaka Koda, Toshio Shinoda","doi":"10.1111/1744-9987.13992","DOIUrl":"10.1111/1744-9987.13992","url":null,"abstract":"<p><strong>Introduction: </strong>Focusing on impacts to health-related indicators in older Japanese patients, this study analyzed both the direct influence of dialysis-related stigma and influences of its intersectionality with other stigmatized characteristics.</p><p><strong>Methods: </strong>Data were collected through a cross-sectional survey of 7461 outpatients in dialysis facilities. Other stigmatized characteristics include lower income, lower education, disabled activities of daily living, and diabetic end-stage renal disease (ESRD) as a cause for starting dialysis treatment.</p><p><strong>Results: </strong>The average rate of an \"agree\" response on dialysis-related stigma items was 18.2%. Dialysis-related stigma significantly influenced all three health-related indicators, including suspected depression, informal networks, and compliance with dietary therapy. In addition, each interaction between dialysis-related stigma and educational attainment, gender, and diabetic ESRD significantly influence one health-related indicator.</p><p><strong>Conclusion: </strong>These results suggest that dialysis-related stigma has both a significant direct and synergic influence with other stigmatized characteristics on health-related indicators.</p>","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10203917","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01Epub Date: 2023-04-18DOI: 10.1111/1744-9987.13994
Leonidas Cruzado Vega, Juan P Moret Chiappe, Alba Santos García
We present the case of an 80-year-old man who received 4-h 3-weekly postdilution online hemodiafiltration (OL-HDF) with a polyethersulfone membrane. He achieved >30 L of convective transport/session and good dialysis adequacy.
{"title":"Severe posthemodialysis thrombocytopenia: What if it's not the heparin?","authors":"Leonidas Cruzado Vega, Juan P Moret Chiappe, Alba Santos García","doi":"10.1111/1744-9987.13994","DOIUrl":"10.1111/1744-9987.13994","url":null,"abstract":"We present the case of an 80-year-old man who received 4-h 3-weekly postdilution online hemodiafiltration (OL-HDF) with a polyethersulfone membrane. He achieved >30 L of convective transport/session and good dialysis adequacy.","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10150989","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01Epub Date: 2023-05-21DOI: 10.1111/1744-9987.14002
Carlota Grifols, Miquel Barceló, Laura Núñez, Zbigniew M Szczepiorkowski, Mercè Boada, Oscar L López, Antonio Páez
Introduction: Little is known about the impact of plasma exchange (PE) on clinical laboratory parameters in Alzheimer's disease (AD) patients.
Methods: AD patients in the AMBAR trial (N = 322) received weekly therapeutic PE (TPE) for 6 weeks followed by monthly low-volume PE (LVPE) for12 months. Treatment were placebo (sham PE), low-albumin, low-albumin + IVIG (i.e., albumin alternated with intravenous immunoglobulin) and high-albumin + IVIG.
Results: Coagulation parameters transiently increased post-TPE. Blood calcium, platelets, and albumin levels decreased but remained within the reference range. Leukocyte counts increased. Fibrinogen, hemoglobin, total protein, gamma globulin, and IgG, transiently dipped below the reference range. Hypogammaglobulinemia (7.2 g/L) persisted in pre-TPE measurements. No changes were observed during the LVPE period. Cerebrospinal fluid parameters and vital signs were unchanged throughout.
Conclusion: Laboratory parameters of AD patients were affected by TPE similarly to effects of PE-treatment for other pathologies. These effects were less pronounced or non-existent for LVPE.
{"title":"Impact of therapeutic and low volume plasma exchange on clinical laboratory parameters in patients treated for Alzheimer's disease from the AMBAR study.","authors":"Carlota Grifols, Miquel Barceló, Laura Núñez, Zbigniew M Szczepiorkowski, Mercè Boada, Oscar L López, Antonio Páez","doi":"10.1111/1744-9987.14002","DOIUrl":"10.1111/1744-9987.14002","url":null,"abstract":"<p><strong>Introduction: </strong>Little is known about the impact of plasma exchange (PE) on clinical laboratory parameters in Alzheimer's disease (AD) patients.</p><p><strong>Methods: </strong>AD patients in the AMBAR trial (N = 322) received weekly therapeutic PE (TPE) for 6 weeks followed by monthly low-volume PE (LVPE) for12 months. Treatment were placebo (sham PE), low-albumin, low-albumin + IVIG (i.e., albumin alternated with intravenous immunoglobulin) and high-albumin + IVIG.</p><p><strong>Results: </strong>Coagulation parameters transiently increased post-TPE. Blood calcium, platelets, and albumin levels decreased but remained within the reference range. Leukocyte counts increased. Fibrinogen, hemoglobin, total protein, gamma globulin, and IgG, transiently dipped below the reference range. Hypogammaglobulinemia (7.2 g/L) persisted in pre-TPE measurements. No changes were observed during the LVPE period. Cerebrospinal fluid parameters and vital signs were unchanged throughout.</p><p><strong>Conclusion: </strong>Laboratory parameters of AD patients were affected by TPE similarly to effects of PE-treatment for other pathologies. These effects were less pronounced or non-existent for LVPE.</p>","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10139000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2023-10-01Epub Date: 2023-04-21DOI: 10.1111/1744-9987.13998
Yuya Sato, Yusuke Takahashi, Kazuyuki Tasaki
Dear Editor, Patients with chronic kidney disease often develop pleural effusion [1], although the latter can also develop in a variety of other conditions [2]. One of these is trapped lung, which may often go undetected. To our knowledge, no case of trapped lung in a patient undergoing regular peritoneal dialysis has been documented in detail hitherto. A 65-year-old male patient with renal failure had been receiving peritoneal dialysis for 6 years before presentation. Although his clinical course had been uneventful, chronic unilateral right pleural effusion had developed several months previously. Therefore, his dose of diuretics had been increased, and the dialysate converted to one with a high glucose concentration. However, the pleural fluid persisted. He was advised to switch to hemodialysis, but declined to do so, mostly because of difficulty with frequent hospital visits. As the pleural fluid was unresponsive to thoracentesis, we performed catheter insertion and drained the fluid sufficiently. During the entire period of drainage, there were no signs suggestive of pneumothorax such as air leakage. Chest computed tomography was performed and this allowed us to make a diagnosis of trapped lung (Figure 1). We suspected that air had entered the thoracic cavity via the catheter from outside as a result of negative pressure that had developed due to the trapped lung. Culture of the pleural fluid was negative for bacteria and mycobacteria, and no malignant cells were evident. The concentration of glucose in the pleural fluid was quite low relative to that of the dialysate, suggesting a lack of pleuroperitoneal communication. After removal of the catheter, the pleural effusion increased again to the previous level within a short period. We started the patient on hemodialysis, but despite intensified body fluid removal, the pleural effusion remained. As the patient complained of only mild exertional dyspnea, we decided that close observation alone would be appropriate. Trapped lung is a condition in which a fibrous layer of visceral pleura surrounds the lung and restricts its expansion [3], resulting in excessive negative intrapleural pressure, and constant formation of pleural fluid. This condition can be associated with several diseases, including pleural infections such as empyema or parapneumonic effusion, immunologic pleuritis, hemothorax, radiation pleuritis or uremia. The present patient's clinical course suggested that no causes other than renal failure had triggered the pleural thickening or the trapped lung. As a relationship between pleural fibrosis and renal failure has been described in the context of uremic pleuritis [4], it may be rational to consider that inadequate efficacy of dialysis might contribute to pleural thickening through sustained pleural inflammation. Therefore, we speculate that if hemodialysis had been started earlier in the present case, it may have prevented development of the trapped lung. However, regardless of t
{"title":"Trapped lung and refractory pleural effusion in a patient receiving peritoneal dialysis.","authors":"Yuya Sato, Yusuke Takahashi, Kazuyuki Tasaki","doi":"10.1111/1744-9987.13998","DOIUrl":"10.1111/1744-9987.13998","url":null,"abstract":"Dear Editor, Patients with chronic kidney disease often develop pleural effusion [1], although the latter can also develop in a variety of other conditions [2]. One of these is trapped lung, which may often go undetected. To our knowledge, no case of trapped lung in a patient undergoing regular peritoneal dialysis has been documented in detail hitherto. A 65-year-old male patient with renal failure had been receiving peritoneal dialysis for 6 years before presentation. Although his clinical course had been uneventful, chronic unilateral right pleural effusion had developed several months previously. Therefore, his dose of diuretics had been increased, and the dialysate converted to one with a high glucose concentration. However, the pleural fluid persisted. He was advised to switch to hemodialysis, but declined to do so, mostly because of difficulty with frequent hospital visits. As the pleural fluid was unresponsive to thoracentesis, we performed catheter insertion and drained the fluid sufficiently. During the entire period of drainage, there were no signs suggestive of pneumothorax such as air leakage. Chest computed tomography was performed and this allowed us to make a diagnosis of trapped lung (Figure 1). We suspected that air had entered the thoracic cavity via the catheter from outside as a result of negative pressure that had developed due to the trapped lung. Culture of the pleural fluid was negative for bacteria and mycobacteria, and no malignant cells were evident. The concentration of glucose in the pleural fluid was quite low relative to that of the dialysate, suggesting a lack of pleuroperitoneal communication. After removal of the catheter, the pleural effusion increased again to the previous level within a short period. We started the patient on hemodialysis, but despite intensified body fluid removal, the pleural effusion remained. As the patient complained of only mild exertional dyspnea, we decided that close observation alone would be appropriate. Trapped lung is a condition in which a fibrous layer of visceral pleura surrounds the lung and restricts its expansion [3], resulting in excessive negative intrapleural pressure, and constant formation of pleural fluid. This condition can be associated with several diseases, including pleural infections such as empyema or parapneumonic effusion, immunologic pleuritis, hemothorax, radiation pleuritis or uremia. The present patient's clinical course suggested that no causes other than renal failure had triggered the pleural thickening or the trapped lung. As a relationship between pleural fibrosis and renal failure has been described in the context of uremic pleuritis [4], it may be rational to consider that inadequate efficacy of dialysis might contribute to pleural thickening through sustained pleural inflammation. Therefore, we speculate that if hemodialysis had been started earlier in the present case, it may have prevented development of the trapped lung. However, regardless of t","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10145101","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Therapeutic Apheresis and Dialysis Forthcoming Events October 2023","authors":"October","doi":"10.1111/1744-9987.13879","DOIUrl":"https://doi.org/10.1111/1744-9987.13879","url":null,"abstract":"","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44851459","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Background: Intradialytic hypotension (IDH) is one of the most important intradialytic complications and is thought to be associated with intradialytic food intake. Allowing intradialytic feeding is still unclear. This study aimed to determine the relationship between IDH and intradialytic food intake.
Methods: A nonrandomized experimental study was conducted to determine the effect of intradialytic food intake on blood pressure (BP) in hemodialysis patients. Each patient was assessed twice using an ambulatory BP monitor with and without intradialytic food intake.
Results: The study was completed with 54 patients. Intradialytic hypotension developed in 40 patients (74.1%) during the food intake session, while intradialytic hypotension developed in 22 participants (40%) in the no-food session. Repeated BP readings showed that eating 2 h or more after the start of hemodialysis significantly reduced BP.
Conclusions: Intradialytic food intake affects the development of IDH. Patients who ate during hemodialysis had a trend of higher of IDH than those who ate nothing during hemodialysis. Eating during dialysis is not recommended.
{"title":"The effect of food intake during hemodialysis on blood pressure: A nonrandomized experimental trial.","authors":"Melek Avci, Fatma Arikan","doi":"10.1111/1744-9987.13967","DOIUrl":"https://doi.org/10.1111/1744-9987.13967","url":null,"abstract":"<p><strong>Background: </strong>Intradialytic hypotension (IDH) is one of the most important intradialytic complications and is thought to be associated with intradialytic food intake. Allowing intradialytic feeding is still unclear. This study aimed to determine the relationship between IDH and intradialytic food intake.</p><p><strong>Methods: </strong>A nonrandomized experimental study was conducted to determine the effect of intradialytic food intake on blood pressure (BP) in hemodialysis patients. Each patient was assessed twice using an ambulatory BP monitor with and without intradialytic food intake.</p><p><strong>Results: </strong>The study was completed with 54 patients. Intradialytic hypotension developed in 40 patients (74.1%) during the food intake session, while intradialytic hypotension developed in 22 participants (40%) in the no-food session. Repeated BP readings showed that eating 2 h or more after the start of hemodialysis significantly reduced BP.</p><p><strong>Conclusions: </strong>Intradialytic food intake affects the development of IDH. Patients who ate during hemodialysis had a trend of higher of IDH than those who ate nothing during hemodialysis. Eating during dialysis is not recommended.</p>","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9762680","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Katsuichi Miyamoto, Nobuaki Nakayama, Hidefumi Ito
Dear Editor, Neuromyelitis optica spectrum disorders (NMOSD) is an immunological neurological disease caused by antiaquqporin-4 (AQP4) antibodies which trigger severe damage to the optic nerve and spinal cord. Steroid pulses are used as treatment in the acute phase of the disease, but not a few cases are unsuccessful, for which apheresis is often later performed [1]. Steroids and immunosuppressive drugs are conventionally used to prevent NMOSD recurrence, but are sometimes inadequate. Biological drugs (biologics) that have emerged in recent years have been shown to be effective in refractory cases. In Japan, biologics were approved for the prevention of relapse starting in November 2019 for eculizumab, an anti-C5 antibody, followed by satralizumab, an anti-IL-6 receptor antibody in August 2020, inebilizumab, an antiCD-19 antibody in March 2021, and rituximab, an antiCD20 antibody in June 2022 [2]. Herein, we present how the clinical characteristics and treatment of NMOSD have changed with the advent of biologics, and discuss the role of apheresis in this treatment. We retrospectively examined patients with NMOSD, diagnosed using the 2015 diagnostic criteria [3], who attended our hospital. Clinical information was
{"title":"Recent changes in the frequency of use of apheresis and biological drugs in the treatment of neuromyelitis optica spectrum disorders.","authors":"Katsuichi Miyamoto, Nobuaki Nakayama, Hidefumi Ito","doi":"10.1111/1744-9987.13977","DOIUrl":"https://doi.org/10.1111/1744-9987.13977","url":null,"abstract":"Dear Editor, Neuromyelitis optica spectrum disorders (NMOSD) is an immunological neurological disease caused by antiaquqporin-4 (AQP4) antibodies which trigger severe damage to the optic nerve and spinal cord. Steroid pulses are used as treatment in the acute phase of the disease, but not a few cases are unsuccessful, for which apheresis is often later performed [1]. Steroids and immunosuppressive drugs are conventionally used to prevent NMOSD recurrence, but are sometimes inadequate. Biological drugs (biologics) that have emerged in recent years have been shown to be effective in refractory cases. In Japan, biologics were approved for the prevention of relapse starting in November 2019 for eculizumab, an anti-C5 antibody, followed by satralizumab, an anti-IL-6 receptor antibody in August 2020, inebilizumab, an antiCD-19 antibody in March 2021, and rituximab, an antiCD20 antibody in June 2022 [2]. Herein, we present how the clinical characteristics and treatment of NMOSD have changed with the advent of biologics, and discuss the role of apheresis in this treatment. We retrospectively examined patients with NMOSD, diagnosed using the 2015 diagnostic criteria [3], who attended our hospital. Clinical information was","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10134477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: The underlying pathophysiology of pulmonary arterial hypertension (PAH) is multifactorial; however, the significance of chronic volume overload and its subsequent effects on cardiac function must be studied thoroughly. The main objective of this study was to determine the predictive parameters of PAH in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) using transthoracic echocardiography (TTE) and bioimpedance analysis (BIA).
Methods: In this cross-sectional study, 43 eligible CAPD patients were chosen. The patients were examined by TTE and BIA before the morning dialysis session, and baseline patient characteristics, echocardiography, and BIA parameters were recorded.
Results: Sixteen (37.2%) patients were diagnosed with PAH. Patients with PAH had significantly greater left atrial diameter (LAD), left ventricular mass index (LVMI), and higher grades of diastolic dysfunction (DDF). Systolic pulmonary artery pressure (sPAP) correlated with LAD (p < 0.001, r = 0.566), interventricular septal diameter (IVSD) (p = 0.004, r = 0.425), LVMI (p = 0.030, r = 0.323), and extracellular water/total body water (ECW/TBW) ratio (p = 0.002, r = 0.458).
Conclusion: Two volume status-related parameters including ECW/TBW ratio and inferior vena cava (IVC) expiratory diameter, and cardiac-related TTE findings such as LAD and DDF were predictors of sPAP in CAPD patients.
{"title":"The significance of volume overload in the development of pulmonary arterial hypertension in continuous ambulatory peritoneal dialysis patients.","authors":"Mohammad Nekooeian, Shahrokh Ezzatzadegan Jahromi, Fatemeh Masjedi, Maryam Sohooli, Ramin Shekouhi, Alireza Moaref","doi":"10.1111/1744-9987.13965","DOIUrl":"https://doi.org/10.1111/1744-9987.13965","url":null,"abstract":"<p><strong>Introduction: </strong>The underlying pathophysiology of pulmonary arterial hypertension (PAH) is multifactorial; however, the significance of chronic volume overload and its subsequent effects on cardiac function must be studied thoroughly. The main objective of this study was to determine the predictive parameters of PAH in patients undergoing continuous ambulatory peritoneal dialysis (CAPD) using transthoracic echocardiography (TTE) and bioimpedance analysis (BIA).</p><p><strong>Methods: </strong>In this cross-sectional study, 43 eligible CAPD patients were chosen. The patients were examined by TTE and BIA before the morning dialysis session, and baseline patient characteristics, echocardiography, and BIA parameters were recorded.</p><p><strong>Results: </strong>Sixteen (37.2%) patients were diagnosed with PAH. Patients with PAH had significantly greater left atrial diameter (LAD), left ventricular mass index (LVMI), and higher grades of diastolic dysfunction (DDF). Systolic pulmonary artery pressure (sPAP) correlated with LAD (p < 0.001, r = 0.566), interventricular septal diameter (IVSD) (p = 0.004, r = 0.425), LVMI (p = 0.030, r = 0.323), and extracellular water/total body water (ECW/TBW) ratio (p = 0.002, r = 0.458).</p><p><strong>Conclusion: </strong>Two volume status-related parameters including ECW/TBW ratio and inferior vena cava (IVC) expiratory diameter, and cardiac-related TTE findings such as LAD and DDF were predictors of sPAP in CAPD patients.</p>","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9732259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Introduction: We evaluated the effect of intradialytic concurrent (resistance-endurance) training combined with melatonin (MEL) supplementation on functional capacity, muscle strength, postural balance, and quality of life (QoL) in hemodialysis (HD) patients.
Methods: Thirty-three HD patients were randomized into three groups: Exercise (EX)-MEL (n = 11); EX-Placebo (PLA) (n = 11) and Control (C)-PLA (n = 11). Participants included in the EX-MEL and EX-PLA groups were submitted to concurrent training for 12 weeks.
Results: EX-MEL and EX-PLA improved functional capacity, muscle strength, QoL, and postural balance parameters in eyes open and eyes closed conditions. Parameters of postural balance in the dual task condition were improved only in EX-MEL. EX-MEL induced better results in some domains of QoL compared with EX-PLA.
Conclusion: Intradialytic concurrent training induced beneficial effects on physical function, muscle strength, postural balance, and QoL in HD patients. MEL supplementation combined with intradialytic exercise lead to better improvements in postural balance and QoL.
{"title":"Effects of intradialytic exercise in combination with melatonin supplementation on functional capacity, postural balance, and quality of life in hemodialysis patients.","authors":"Houssem Marzougui, Rami Maaloul, Imen Ben Dhia, Salma Toumi, Khawla Kammoun, Mohamed Ben Hmida, Fatma Ayadi, Mouna Turki, Mohamed Habib Elleuch, Sameh Ghroubi, Omar Hammouda","doi":"10.1111/1744-9987.13964","DOIUrl":"https://doi.org/10.1111/1744-9987.13964","url":null,"abstract":"<p><strong>Introduction: </strong>We evaluated the effect of intradialytic concurrent (resistance-endurance) training combined with melatonin (MEL) supplementation on functional capacity, muscle strength, postural balance, and quality of life (QoL) in hemodialysis (HD) patients.</p><p><strong>Methods: </strong>Thirty-three HD patients were randomized into three groups: Exercise (EX)-MEL (n = 11); EX-Placebo (PLA) (n = 11) and Control (C)-PLA (n = 11). Participants included in the EX-MEL and EX-PLA groups were submitted to concurrent training for 12 weeks.</p><p><strong>Results: </strong>EX-MEL and EX-PLA improved functional capacity, muscle strength, QoL, and postural balance parameters in eyes open and eyes closed conditions. Parameters of postural balance in the dual task condition were improved only in EX-MEL. EX-MEL induced better results in some domains of QoL compared with EX-PLA.</p><p><strong>Conclusion: </strong>Intradialytic concurrent training induced beneficial effects on physical function, muscle strength, postural balance, and QoL in HD patients. MEL supplementation combined with intradialytic exercise lead to better improvements in postural balance and QoL.</p>","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9732260","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Balzan Deborah, Stefanie Marie Agius, Farrugia Emanuel, Buttigieg Jesmar
Introduction: Dialysis patients are at increased risk of severe COVID-19 infection making vaccination a priority. We explored COVID-19 vaccine uptake and perceptions in our dialysis population, associated COVID-19 infection, and hospitalization rates.
Methods: This is a single-center retrospective study using telephone questionnaires and hospital records to investigate COVID-19 vaccine uptake and attitudes behind vaccination status.
Results: A total of 230 patients were interviewed. Vaccine uptake was 97.8% (two doses) and 86.6% (booster dose), with 79.5% vaccinated at Renal Unit. Most (58.5%) cited healthcare worker advice as a contributing factor and 54% sought protection through vaccination. COVID-19 hospitalization was higher in unvaccinated and patients vaccinated with one dose, compared to two doses (63.2% vs. 20%, p = 0.05) and booster dose (63.2% vs. 22.2%, p = 0.02).
Conclusion: Our dialysis population recognized the importance of COVID-19 vaccination. Intensive patient education and easy access to the COVID-19 vaccine may have facilitated vaccine uptake in these patients.
导言:透析患者发生COVID-19严重感染的风险增加，因此需要优先接种疫苗。我们探讨了透析人群中COVID-19疫苗的摄取和认知、相关的COVID-19感染和住院率。方法:采用电话问卷和医院记录进行单中心回顾性研究，调查COVID-19疫苗接种情况和疫苗接种态度。结果:共访谈230例患者。疫苗接种率为97.8%(两剂)和86.6%(加强剂)，其中79.5%在肾科接种。大多数(58.5%)认为卫生保健工作者的建议是促成因素，54%的人通过接种疫苗寻求保护。未接种疫苗和接种一剂疫苗的患者的COVID-19住院率高于两剂(63.2% vs. 20%， p = 0.05)和加强剂(63.2% vs. 22.2%， p = 0.02)。结论:透析人群认识到COVID-19疫苗接种的重要性。强化患者教育和易于获得COVID-19疫苗可能促进了这些患者接种疫苗。
{"title":"COVID-19 vaccine uptake rates, perceptions, and attitudes among dialysis patients: Experience across a national sample.","authors":"Balzan Deborah, Stefanie Marie Agius, Farrugia Emanuel, Buttigieg Jesmar","doi":"10.1111/1744-9987.13983","DOIUrl":"https://doi.org/10.1111/1744-9987.13983","url":null,"abstract":"<p><strong>Introduction: </strong>Dialysis patients are at increased risk of severe COVID-19 infection making vaccination a priority. We explored COVID-19 vaccine uptake and perceptions in our dialysis population, associated COVID-19 infection, and hospitalization rates.</p><p><strong>Methods: </strong>This is a single-center retrospective study using telephone questionnaires and hospital records to investigate COVID-19 vaccine uptake and attitudes behind vaccination status.</p><p><strong>Results: </strong>A total of 230 patients were interviewed. Vaccine uptake was 97.8% (two doses) and 86.6% (booster dose), with 79.5% vaccinated at Renal Unit. Most (58.5%) cited healthcare worker advice as a contributing factor and 54% sought protection through vaccination. COVID-19 hospitalization was higher in unvaccinated and patients vaccinated with one dose, compared to two doses (63.2% vs. 20%, p = 0.05) and booster dose (63.2% vs. 22.2%, p = 0.02).</p><p><strong>Conclusion: </strong>Our dialysis population recognized the importance of COVID-19 vaccination. Intensive patient education and easy access to the COVID-19 vaccine may have facilitated vaccine uptake in these patients.</p>","PeriodicalId":23021,"journal":{"name":"Therapeutic Apheresis and Dialysis","volume":null,"pages":null},"PeriodicalIF":1.9,"publicationDate":"2023-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9741219","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号